CASP, the protein structure prediction contest that launched DeepMind’s AlphaFold to international fame and a Nobel Prize, ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

About six months after coming out of stealth with $50 million in funding, Latent Labs has released a web-based AI model for ...

Google’s GNoME AI might be the most important scientific discovery tool since AlphaFold. By identifying novel, stable ...

Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...

Demis Hassabis, the cofounder and CEO of DeepMind, is one of three researchers to be awarded the Nobel Prize in chemistry.

DeepMind’s AlphaFold program has been upgraded since last year’s CASP competition and is now 16 times faster. “We can fold an average protein in a matter of minutes, ...

AlphaFold’s strategy is similar to most entries in CASP this year, in that it relies on deep learning. Remember: amino acid sequences, the building blocks of proteins, contain data about a protein’s ...

AlphaFold's achievements In 2018, DeepMind entered AlphaFold into the 13th Critical Assessment of Structure Prediction (CASP) competition, a biannual experiment founded in 1994.

The Rise of AlphaFold as a Standard Laboratory Tool And Applications in Drug Discovery Serendipitously, on the 20th of September, 2023, I was having coffee with Dr. Michael Levitt. In 2013 ...

AlphaFold 3 represents a significant milestone in AI-powered molecular discovery, but it is just the beginning. As researchers continue to push the boundaries of what’s possible with these ...

Researchers used AlphaFold and homology modeling to identify potent TAAR1 agonists, showing AlphaFold's superior performance in drug discovery for neuropsychiatric conditions.